How to diagnose Myasthenia Gravis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis of Myasthenia Gravis

The diagnosis of myasthenia gravis requires a combination of clinical evaluation, serological testing for specific antibodies, and electrodiagnostic studies, with anti-acetylcholine receptor (AChR) antibody testing being the primary diagnostic test for confirmation.

Clinical Presentation

  • Fatigable or fluctuating muscle weakness, typically more proximal than distal, is the hallmark clinical presentation of myasthenia gravis 1
  • Ocular symptoms (ptosis, diplopia) are common initial manifestations, with generalization to other muscle groups occurring in approximately 80% of cases 2
  • Bulbar involvement may present as dysphagia, dysarthria, and facial muscle weakness 1
  • Symptoms worsen with repeated use of affected muscles and improve with rest 3

Primary Diagnostic Tests

  • Anti-acetylcholine receptor (AChR) antibody testing is recommended as the first-line diagnostic test, with positive results in approximately 80% of patients with generalized myasthenia gravis but only about 50% of patients with purely ocular myasthenia 4
  • Anti-muscle-specific kinase (MuSK) antibody testing should be performed when AChR antibodies are negative, as approximately one-third of seronegative patients will be positive for anti-MuSK antibodies 4
  • Single-fiber electromyography (SFEMG) is considered the gold standard diagnostic test with over 90% sensitivity, particularly valuable for ocular myasthenia gravis 4
  • Repetitive nerve stimulation testing has lower sensitivity than SFEMG, being positive in only about one-third of patients with ocular myasthenia 4

Bedside Diagnostic Tests

  • The ice pack test is highly specific and involves applying an ice pack over closed eyes for 2 minutes to evaluate for improvement in ptosis 4, 1
  • The edrophonium (Tensilon) test should be performed in a monitored setting with atropine available due to potential muscarinic side effects 4
    • For adults: 2 mg IV initially, followed by remaining 8 mg if no reaction occurs after 45 seconds 5
    • A positive test shows increased muscle strength in untreated myasthenics 5
    • The test has 95% sensitivity for generalized myasthenia and 86% sensitivity for ocular myasthenia 4

Additional Diagnostic Evaluations

  • Pulmonary function assessment, including negative inspiratory force and vital capacity measurements, is crucial to evaluate respiratory muscle involvement 4, 1
  • Laboratory tests for possible concurrent conditions:
    • Creatine phosphokinase (CPK), aldolase, ESR, and CRP to evaluate for possible concurrent myositis 4
    • Cardiac evaluation (ECG, echocardiogram) if respiratory insufficiency or elevated CPK/troponin T is present 4
  • MRI of brain and/or spine may be needed to rule out alternative diagnoses depending on symptoms 4

Diagnostic Algorithm

  1. Clinical evaluation for fatigable weakness
  2. Serological testing:
    • Anti-AChR antibodies (first)
    • If negative, test for anti-MuSK antibodies
  3. Electrodiagnostic studies:
    • Single-fiber EMG (most sensitive)
    • Repetitive nerve stimulation
  4. Bedside tests:
    • Ice pack test
    • Edrophonium (Tensilon) test in monitored setting

Important Considerations and Pitfalls

  • Avoid medications that can exacerbate myasthenia symptoms during testing, including β-blockers, IV magnesium, fluoroquinolones, aminoglycosides, and macrolides 4, 1
  • Myasthenic crisis must be distinguished from cholinergic crisis, as management differs significantly 5
  • False-negative antibody tests can occur, particularly in purely ocular myasthenia, making clinical evaluation and electrodiagnostic studies essential 4, 2
  • Myasthenia gravis can be associated with thymoma in approximately 20% of patients and with other autoimmune diseases such as hyperthyroidism and Hashimoto's disease 2

Response Patterns to Edrophonium Testing

  • Myasthenic response: Increased muscle strength (diagnostic in untreated patients) 5
  • Adequate response: No change in muscle strength (seen in treated patients with stabilized therapy) 5
  • Cholinergic response: Decreased muscle strength with side effects like lacrimation, diaphoresis, salivation (indicates overtreatment) 5

References

Guideline

Diagnostic Criteria and Treatment Options for Myasthenia Gravis (MG)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Laboratory Testing for Myasthenia Gravis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.